How AI helps humans in a safe and trustworthy manner in safety critical environments
Grant and Award Announcement
SMU Associate Professor Pradeep Varakantham is working with the Singapore Civil Defence Force to create a digital programme to provide faster and more comprehensive paramedic training.
New research, led by SMU Associate Professor Shih-Fen Cheng, is utilising big data from Singapore's transport gig economy to evaluate how and at what rate individuals learn over time.
Researchers led by Prof. WU Zhengyan from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS), the Institute of Health and Medical Technology and the Binzhou Medical University fabricated a series of Gd-doped iron oxide nanoclusters to systemically study the inherent mechanism through which Gd doping tune the T2 contrast ability of the nanoclusters.
SMU Associate Professor Marko Pitesa’s research aims to design an intervention plan to leverage mid-career job opportunities, particularly for lower-SES employees.
University of Tsukuba researchers identified warm conditions in the Indian Ocean as a major factor driving both warm winters and extreme summer rainfall in central China and Japan. An anomalous anticyclone in the subtropical western Pacific was strongly associated with the provision of moisture to sustain the extreme rainfall, leading to catastrophic flooding events. These observations could be applied to future forecasting and prediction of extreme summer rainfall in East Asia.
New research published in Stem Cell Reports has found elevated cholesterol supply from astrocytes to neurons in the model of Alzheimer's disease (AD) brains, suggesting that modulating brain cholesterol could be explored in the search of treatment options for the devastating, degenerative disease.
Using light beads microscopy, researchers can now capture images of a vast number of cells across different depths in the brain at high speed, with unprecedented clarity.
The Crohn’s & Colitis Foundation (the Foundation) announced today that it received a $3 million donation from Jonathan D. Rose, MD, PhD, to support two major Foundation research programs: IBD-SIRCQ, a national, prospective surgical cohort, and the Jonathan D. Rose, MD, PhD, Crohn’s & Colitis Foundation / Cedars-Sinai Pathology in Precision Medicine Research Collaborative.
The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The NIH REsearching COVID to Enhance Recovery (RECOVER) Initiative made the parent award to New York University (NYU) Langone Health, New York City, which will make multiple sub-awards to more than 100 researchers at more than 30 institutions and serves as the RECOVER Clinical Science Core. This major new award to NYU Langone supports new studies of COVID-19 survivors and leverages existing long-running large cohort studies with an expansion of their research focus. This combined population of research participants from new and existing cohorts, called a meta-cohort, will comprise the RECOVER Cohort. This funding was supported by the American Rescue Plan.
Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations by structure and function provides an accurate framework to match patients with non-small cell lung cancer (NSCLC) to the right drugs. The findings, published in Nature, identify four subgroups of mutations and introduce a new strategy for testing tyrosine kinase inhibitors (TKIs), as well as instant clinical opportunities for approved targeted therapies.
Researchers at McMaster University have developed a sophisticated new tool that could help provide early warning of rare and unknown viruses in the environment and identify potentially deadly bacterial pathogens which cause sepsis, among other uses.
The chemical steps involved in an important cellular modification process that adds a chemical tag to some RNAs has been revealed in a new study by Penn State researchers. Interfering with this process in humans can lead to neuronal diseases, diabetes, and cancers.